Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 294
Selected: 0
NCT IDTitle
NCT02309944Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT00888316Iron Overload in Patients Undergoing Donor Stem Cell Transplant
NCT05809557EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
NCT06584929Rural Smoking Cessation
NCT00354172Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
NCT01144442WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
NCT01581970Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
NCT00167180Post Transplant Donor Lymphocyte Infusion
NCT01505569Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
NCT00622674Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
NCT00258362Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
NCT00287911Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
NCT01572636Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome
NCT00373152MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer
NCT00303719Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
NCT03728699Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
NCT01666080Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
NCT01099631IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
NCT01181258Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
NCT03125642Auto Stem Cell Transplant for Lymphoma Patients
NCT02227797MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
NCT05322408HCW9218 in Select Advanced Solid Tumors
NCT01106950Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)
NCT06342986Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT07493538MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
NCT05308316Sugars in Cigarettes
NCT00176826T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
NCT00176917Stem Cell Transplantation for Hurler
NCT02661035Allo HSCT Using RIC for Hematological Diseases
NCT01885897IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
NCT01158456Metabolism of NNK Among African Americans
NCT05634512Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
NCT01685411Busulfan and Cyclophosphamide Followed By ALLO BMT
NCT02395822MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients
NCT02988843Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors
NCT02410239MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)
NCT00630253Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia
NCT01526603High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
NCT00346125PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
NCT00095160Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors
NCT00703638Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT01634217Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
NCT00295880Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
NCT02156674Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
NCT00176865Stem Cell Transplant for Immunologic or Histiocytic Disorders
NCT00680667Clinical Trial of Trametes Versicolor in Women With Breast Cancer
NCT00612716Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
NCT06872333Allo HSCT for High Risk Hemoglobinopathies
NCT00895414Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer